We are live on ! Find out more
KC

Kepos Capital Portfolio holdings

AUM $61.3M
1-Year Est. Return 12.13%
This Fund
S&P 500
This Quarter Est. Return
+5.16%
1 Year Est. Return
+12.13%
3 Year Est. Return
+22.16%
5 Year Est. Return
10 Year Est. Return
AUM
$1.95B
AUM Growth
-$10.4M
Cap. Flow
-$68.4M
Cap. Flow %
-3.51%
Top 10 Hldgs %
37.73%
Holding
461
New
135
Increased
72
Reduced
43
Closed
123

Sector Composition

Rank Sector Weight
1 Healthcare 18.57%
2 Financials 8.49%
3 Communication Services 8.34%
4 Technology 7.52%
5 Consumer Discretionary 5.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FSACW
176
DELISTED
Federal Street Acquisition Corp. Warrant
FSACW
$1.73M 0.09%
1,196,041
TGT icon
177
Target
TGT
$65.5B
$1.71M 0.09%
19,419
+4,995
+35% +$415K
TIBRW
178
DELISTED
Tiberius Acquisition Corporation Warrant
TIBRW
$1.71M 0.09%
2,904,200
ENTA icon
179
Enanta Pharmaceuticals
ENTA
$365M
$1.71M 0.09%
+19,996
New +$2M
CMA
180
DELISTED
Comerica
CMA
$1.67M 0.09%
+18,484
New +$1.76M
IMMR icon
181
Immersion
IMMR
$253M
$1.65M 0.08%
156,125
+95,000
+155% +$1.19M
MOS icon
182
The Mosaic Company
MOS
$7.3B
$1.62M 0.08%
+49,987
New +$1.51M
ARRY
183
DELISTED
Array Biopharma Inc
ARRY
$1.59M 0.08%
104,545
TPGH.WS
184
DELISTED
TPG Pace Holdings Corp. Warrants, each exercisable for one Class A Ordinary Share at an exercise pri
TPGH.WS
$1.56M 0.08%
890,000
LGC.WS
185
DELISTED
Legacy Acquisition Corp. Warrants, exercisable for one-half of one share of Class A Common Stock for
LGC.WS
$1.53M 0.08%
3,450,390
+550
+0% +$257
PTCT icon
186
PTC Therapeutics
PTCT
$6.17B
$1.52M 0.08%
32,294
TRAW icon
187
Traws Pharma
TRAW
$7.9M
$1.47M 0.08%
533
TBRGW
188
DELISTED
Thunder Bridge Acquisition, Ltd. Warrant
TBRGW
$1.46M 0.08%
+3,250,000
New +$1.59M
FCNCA icon
189
First Citizens BancShares
FCNCA
$25B
$1.45M 0.07%
3,203
-730
-19% -$322K
TUSK icon
190
Mammoth Energy Services
TUSK
$128M
$1.42M 0.07%
48,839
+31,089
+175% +$1.02M
CF icon
191
CF Industries
CF
$18.9B
$1.41M 0.07%
+25,817
New +$1.24M
VEACW
192
DELISTED
Vantage Energy Acquisition Corp.
VEACW
$1.4M 0.07%
1,033,310
+35,800
+4% +$52.4K
ALNY icon
193
Alnylam Pharmaceuticals
ALNY
$38.3B
$1.39M 0.07%
15,860
SAM icon
194
Boston Beer
SAM
$1.92B
$1.38M 0.07%
+4,787
New +$1.44M
SIX
195
DELISTED
Six Flags Entertainment Corp.
SIX
$1.36M 0.07%
19,441
-6,155
-24% -$418K
AGO icon
196
Assured Guaranty
AGO
$3.76B
$1.35M 0.07%
31,927
-30,848
-49% -$1.22M
INGN icon
197
Inogen
INGN
$174M
$1.32M 0.07%
+5,424
New +$1.25M
LACQW
198
DELISTED
Leisure Acquisition Corp. Warrant
LACQW
$1.3M 0.07%
1,214,100
+174,500
+17% +$161K
AKRX
199
DELISTED
Akorn Inc
AKRX
$1.3M 0.07%
100,000
MFAC.WS
200
DELISTED
Megalith Financial Acquisition Corp. Warrants, each warrant exercisable for one share of Class A Com
MFAC.WS
$1.27M 0.07%
+2,125,000
New +$1.28M

Similar funds

Kepos Capital's Q3 2018 Portfolio in Review

As of Q3 2018, Kepos Capital held 461 positions worth $1.95B, down 0.53% from $1.96B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Kepos Capital withdrew a net $68.4M in Q3 2018, closing 123 positions and reducing 43 holdings. Its most notable exit was NXP Semiconductors, an estimated $76.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 12% a quarter earlier, followed by Financials and Communication Services.

Against the trend, Kepos Capital opened a new position in Constellation Brands worth $42.2M.

  • Kepos Capital's largest Q3 2018 buy was Constellation Brands: 195,530 shares worth $42.2M.
  • Kepos Capital added most to Shire pic in Q3 2018, an estimated $58.8M increase.
  • Kepos Capital's biggest Q3 2018 reduction was Twenty-First Century Fox, Inc. Class A, cutting an estimated $48.1M.
  • Kepos Capital fully exited NXP Semiconductors in Q3 2018, selling an estimated $76.5M.
  • Kepos Capital's ten largest holdings make up 38% of its $1.95B portfolio in Q3 2018.
  • Kepos Capital opened 135 new positions and closed 123 in Q3 2018.
  • Kepos Capital's portfolio value fell 0.53% quarter-over-quarter to $1.95B.

Based on Kepos Capital's 13F filing for Q3 2018, filed 13 Nov 2018.